Search Results - "Williams, Shelly M."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Tumor Lysis Syndrome by Williams, Shelly M, Killeen, Anthony A

    “…Tumor lysis syndrome (TLS) is an acute, life-threatening disease among adults and children that is associated with the initiation of cytoreductive therapy in…”
    Get full text
    Journal Article
  2. 2

    Characteristics of HPC(A) product obtained from a donor with SARS-CoV-2 infection and outcome of autologous transplant by Renavikar, Pranav S, Warkentin, Phyllis I, Williams, Shelly M, Gundabolu, Krishna, Branson, Charles, Koepsell, Scott A

    Published in Stem cell research & therapy (13-08-2024)
    “…Collection of hematopoietic progenitor cell products [HPC(A)] is deferred if the donor is symptomatic and tests positive for Covid-19. However, donor…”
    Get full text
    Journal Article
  3. 3

    Identification of Genes Responsible for Osteoblast Differentiation from Human Mesodermal Progenitor Cells by Qi, Huilin, Aguiar, Dean J., Williams, Shelly M., La Pean, Alison, Pan, Wei, Verfaillie, Catherine M.

    “…Single human bone marrow-derived mesodermal progenitor cells (MPCs) differentiate into osteoblasts, chondrocytes, adipocytes, myocytes, and endothelial cells…”
    Get full text
    Journal Article
  4. 4

    Handling the different requirements for commercial and investigational MNC collections by apheresis by Bobr, Aleh, Roberts, Timothy, Koepsell, Scott, Williams, Shelly M., Schwartz, Joseph

    Published in Cytotherapy (Oxford, England) (01-08-2024)
    “…With the success of chimeric antigen receptor T-cell (CAR-T) and similar cellular-based therapies, the demand for collection of autologous mononuclear cells by…”
    Get full text
    Journal Article
  5. 5

    Two acute psychiatric emergencies and prevalence of mental health disorders at an outpatient apheresis clinic: Implications for apheresis practitioners by Williams, Shelly M., Bobr, Aleh, Koepsell, Scott A.

    Published in Journal of clinical apheresis (01-02-2023)
    “…The prevalence of mental health disorders among apheresis patients is unknown. Patients with chronic conditions treated with apheresis in the outpatient…”
    Get full text
    Journal Article
  6. 6

    Infusion reactions in natural killer cell immunotherapy: a retrospective review by Mamo, Tewodros, Williams, Shelly M., Kinney, Stephanie, Tessier, Katelyn M., DeFor, Todd E., Cooley, Sarah, Miller, Jeffrey S., McKenna, David H.

    Published in Cytotherapy (Oxford, England) (01-07-2021)
    “…The use of natural killer (NK) cells as a cellular immunotherapy has increased over the past decade, specifically in patients with hematologic malignancies. NK…”
    Get full text
    Journal Article
  7. 7

    Clinical‐scale production of cGMP compliant CD3/CD19 cell‐depleted NK cells in the evolution of NK cell immunotherapy at a single institution by Williams, Shelly M., Sumstad, Darin, Kadidlo, Diane, Curtsinger, Julie, Luo, Xianghua, Miller, Jeffrey S., McKenna, David H.

    Published in Transfusion (Philadelphia, Pa.) (01-06-2018)
    “…BACKGROUND Allogeneic natural killer (NK) cell adoptive immunotherapy is a growing therapeutic option for patients. Clinical‐scale production of NK cells using…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Newborn Screening for Sickle Cell Disease in St. Vincent and the Grenadines: Results of a Pilot Newborn Screening Program by Williams, Shelly-Ann, Browne-Ferdinand, Beneka, Smart, Ynolde, Morella, Kristen, Reed, Susan G., Kanter, Julie

    Published in Global pediatric health (2017)
    “…Objective: To pilot a newborn screening program for sickle cell disease (SCD) in St. Vincent and the Grenadines using a novel partnership method to determine…”
    Get full text
    Journal Article